AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05671341 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Assessment
Description: Tandem walking test, Tandem Stance test, Activity-specific Balance Confidence Parkinson's Disease Quality of Life-8 N/L ratio Tinetti Balance Test UPDRS
Study NCT06583187 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Coloring a mandala picture
Description: In the study, the experimental group was taken to their room on the day they came for circumcision and then had them paint mandalas. The coloring books chosen for mandala painting were determined to be appropriate for the age group of the children. The child was given a book and was given the freedom to paint the figures they wanted. Care was taken to ensure that the environment was quiet so that the child would be comfortable and calm. Care was taken to ensure that the crayons used in mandala painting did not contain carcinogenic substances and were anti-allergic.
Study NCT04899362 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BB-RIC-D1/LAPUL Medical Devices Co, Ltd, China
Description: The RIC consisted of 4 cycles of extremities ischemia (5-minute blood pressure cuff inflation to 200 mm Hg, followed by 5-minute cuff deflation). The tourniquets were applied to one side upper arm. This intervention was undertaken twice a day for 7 days.
Study NCT04899362 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intravenous blood collection
Description: Nurses will collect intravenous blood 3ml four times (at baseline and the first, seventh and eighth day of the study).The blood samples will be stored for laboratory test.The blood samples only use for the trial.
Study NCT04899362 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: dCA measurement
Description: Serial measurements of dCA were performed at 10 days, baseline, 1st, 2ed, 4th, 7th, 8th, 10th, 14th, 21th and 35th of the study.The continuous ABP was measured non-invasively using a servo-controlled plethysmograph (Finometer Pro, the Netherlands) at the middle finger. Two 2 MHz transcranial Doppler probe was used to measure continuous cerebral blood flow velocity (CBFV) simultaneously in the bilateral middle cerebral arteries at a depth of 45-60 mm Endtidal CO2 was monitored using a capnograph (MultiDop X2, DWL, Sipplingen, Germany). The probes were placed over temporal windows and fixed with a customized head frame. CBFV and continuous arterial blood pressure were recorded simultaneously from each subject in the supine position for 10 minutes. All data were recorded for further assessment and analysis.
Study NCT05005468 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab
Description: Camrelizumab is given on the first day of each cycle, intravenous drip.
Study NCT05005468 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Famitinib
Description: Famitinib is administered orally, once a day.
Study NCT05700526 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Planning of multiplanar and/or multifocal osteotomies in children by using VSP, PSIs and customized structural bone allograft
Description: Preoperative VSP is performed starting from 3D digital models obtained from DICOM data of CT-scan with a segmentation process. If applicable, a model of the contralateral limb is obtained and used as reference for the correction. The surgeon and the engineer together define the surgical strategy, establishing the correction, the design of Patient-Specific Instruments (PSIs) and the hardware to implant. Then, through VSP, an ideal model of the bone graft is designed.
Study NCT05700526 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Planning of multiplanar and/or multifocal osteotomies in children by using VSP, PSIs and customized structural bone allograft
Description: Preoperative VSP is performed starting from 3D digital models obtained from DICOM data of CT-scan with a segmentation process. If applicable, a model of the contralateral limb is obtained and used as reference for the correction. The surgeon and the engineer together define the surgical strategy, establishing the correction, the design of Patient-Specific Instruments (PSIs) and the hardware to implant. Then, through VSP, an ideal model of the bone graft is designed.
Study NCT05700526 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Routine preparation of bone graft according to standard protocols
Description: The size dimensions obtained through VSP are used by the tissue bank to manually cut a structural bone graft according to the standard protocols.
Study NCT05700526 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Preparation of bone graft with virtual bone-matching and GSIs
Description: The best donor bone is identified by matching the 3D models provided by bone bank with the planned graft, considering not only the size but also the most suitable configuration of cortical and medullary bone. Then GSIs are designed and 3D printed to perform the exact cut on the donor bone according to the experimental protocol.
Study NCT05700526 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Corrective osteotomy
Description: The acute surgical correction is performed according to VSP using PSI and the customized bone graft. Preoperative variables (age, sex, disease, deformity), intraoperative variables (operation time, intraoperative complications, use of fluoroscopy, intraoperative bleeding) are registered.
Study NCT05700526 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Corrective osteotomy
Description: The acute surgical correction is performed according to VSP using PSI and the customized bone graft. Preoperative variables (age, sex, disease, deformity), intraoperative variables (operation time, intraoperative complications, use of fluoroscopy, intraoperative bleeding) are registered.
Study NCT05794126 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lens 1
Description: Soft multifocal hydrogel contact lens for 15 minutes
Study NCT05794126 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lens 2
Description: Soft multifocal silicone hydrogel contact lens for 15 minutes.
Study NCT05487950 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rivaroxaban group
Description: Patients assigned in the Rivaroxaban group will receive 15 mg once day or 10 mg if dosage modification is needed due to renal insufficiency (Creatinine clairance calculated with the Cockroft formula between 30 or 49 ml/min).
Study NCT05580250 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3526318
Description: Administered orally.
Study NCT05580250 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered orally.
Study NCT05580250 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iohexol
Description: Administered intravenously (IV).
Study NCT05580250 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Simvastatin
Description: Administered orally.
Study NCT06406738 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Using High Reality Simulator
Description: Using High Reality Simulator will perform newborn first-care.
Study NCT05541107 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MAT2203
Description: oral lipid nanocrystal amphotericin B
Study NCT05541107 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amphotericin B
Description: Intravenous Amphotericin B
Study NCT04899219 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACT-1014-6470 40 mg
Description: ACT-1014-6470 will be available as soft gelatin capsules for oral administration formulated at a dose strength of 20 mg.
Study NCT05483569 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Complex Decongestive Physiotherapy
Description: Complete or complex decongestive physiotherapy (CDP) is a treatment for lymphedema, a condition in which excess fluid (lymph) collects in a part of the body. Damage to the lymph nodes or vessels, or a blockage leading to chronic swelling, usually causes lymphedema.
Study NCT05483569 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multidimensional Diaphragmatic Breathing Exercises
Description: Diaphragmatic breathing is an exercising technique to help strengthen your diaphragm and fill your lungs with air more efficiently.
Study NCT05483569 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Facial Release Technique
Description: Fascial release is a manual therapy method that is applied holistically to the muscles and surrounding fascia through mechanical stimulation. It is a comprehensive approach to the evaluation and treatment of the muscular and fascia system in the body.
Study NCT06651216 — intervention group
Intervention type: OTHER
Intervention: Stool analysis
Description: Analysis of infant fecal microbiota
Study NCT06651216 — intervention group
Intervention type: OTHER
Intervention: breast milk analysis
Description: Analysis of the effect of breast milk miRNAs on infant fecal microbiota
Study NCT06002828 — intervention group
Intervention type: PROCEDURE
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples
Study NCT06002828 — intervention group
Intervention type: OTHER
Intervention: Quality-of-Life Assessment
Description: Complete questionnaires
Study NCT06002828 — intervention group
Intervention type: OTHER
Intervention: Questionnaire Administration
Description: Complete questionnaires
Study NCT03434548 — intervention group
Intervention type: RADIATION
Intervention: PET imaging
Description: PET imaging Radiation: Radioligand \[¹¹C\]MePPEP Intravenous injection of radioligand in the arm with PET imaging of the brain. Radiation: Radioligand \[¹¹C\]IMA107 Intravenous injection of radioligand in the arm with PET imaging of the brain. Radiation: Radioligand \[¹¹C\]MDL100907 Intravenous injection of radioligand in the arm with PET imaging of the brain. Radiation: Radioligand \[¹¹C\]MDL100907 Intravenous injection of radioligand in the arm with PET imaging of the brain.~PET imaging Radiation: Radioligand \[¹¹C\]MePPEP Intravenous injection of radioligand in the arm with PET imaging of the brain. Radiation: Radioligand \[¹¹C\]IMA107 Intravenous injection of radioligand in the arm with PET imaging of the brain. Radiation: Radioligand \[¹¹C\]MDL100907 Intravenous injection of radioligand in the arm with PET imaging of the brain. Radiation: Radioligand \[¹¹C\]MDL100907 Intravenous injection of radioligand in the arm with PET imaging of the brain.
Study NCT03434548 — intervention group
Intervention type: OTHER
Intervention: Multi-modal MRI imaging
Description: Multi-modal MRI imaging
Study NCT05697341 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultra-Mini-PCNL
Description: treatment to extract or disintegrate renal stones
Study NCT05697341 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Stented SWL
Description: treatment to disintegrate renal stones in the presence of a JJ
Study NCT06039995 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Comprehensive Oral Care
Description: The intervention mentioned in this study involves a combination of oral care strategies for patients in the intervention group. These strategies include:~Chlorhexidine Mouthwash: Patients in the intervention group will receive Chlorhexidine mouthwash. Chlorhexidine is known for its effectiveness in maintaining oral hygiene.~Toothbrushing: In addition to Chlorhexidine mouthwash, patients in the intervention group will undergo toothbrushing. This involves cleaning the teeth and surrounding oral tissues to ensure thorough oral hygiene.~Moisturizing Gel Application: The intervention group will also receive the application of moisturizing gel on the interior and exterior surfaces of the oral cavity. This helps in maintaining the moisture content of the oral tissues.~These interventions aim to enhance oral care beyond traditional methods, potentially reducing the risk of Ventilator-Associated Pneumonia (VAP) and improving overall patient outcomes in the intensive care unit (ICU).
Study NCT06039995 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Oral Care
Description: In the control arm, patients receive the intervention known as Traditional Oral Care. This involves the use cotton swab dipped in 0.2% Chlorhexidine mouthwash for oral hygiene.
Study NCT06039995 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mechanical Tooth Brushing using 0.2% Chlorhexidine
Description: Toothbrushing: In addition to Chlorhexidine mouthwash, patients in the intervention group will undergo toothbrushing. This involves cleaning the teeth and surrounding oral tissues to ensure thorough oral hygiene.
Study NCT06039995 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Moisturizing Gel
Description: Moisturizing Gel Application: The intervention group will also receive the application of moisturizing gel on the interior and exterior surfaces of the oral cavity. This helps in maintaining the moisture content of the oral tissues.
Study NCT06039995 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Oral care using Cotton swab dipped in 0.2% Chlorhexidine
Description: This involves the use cotton swab dipped in 0.2% Chlorhexidine mouthwash for oral hygiene
Study NCT05820282 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Volitional help sheet
Description: Participants are asked to choose from a list of strategies for increasing delivery of behaviour change interventions
Study NCT05820282 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control condition
Description: Participants are asked to identify situations and solutions and place a tick next to each one they think would be useful to them. Therefore, participants in the control condition are not asked to form implementation intentions.
Study NCT06713330 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BioFLX crown
Description: Device: BioFLX crown
Study NCT06713330 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: 3M Stainless Steel Crown
Description: 3M Stainless Steel Crown
Study NCT06726486 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Atémpero
Description: A complete hyperproteic and hypercaloric diet with a mixture of fibres enriched in omega 3, L-arginine and nucleotides (which provides vitamin C and Zinc) was administered.
Study NCT05580250 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: Administered orally.
Study NCT04813770 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Theory-based messages
Description: COVID-19 vaccination information structured to address vaccination necessity and concerns.
Study NCT04813770 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: General messages
Description: General messages about the COVID-19 virus and the vaccination programme.
Study NCT05548023 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: The AngioliteTM Durable Fluoroacrylate Polymer-based Sirolimus-Eluting Stent
Description: The Angiolite stent is a thin-strut cobalt-chromium sirolimus-eluting stent with an open-cell design and a high overexpansion capacity that might overcomes some of these challenges in LMCA PCI. The ANGIOLITE randomized trial confirmed the non-inferiority of the Angiolite stent against the conventional DES
Study NCT06146530 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Treatment
Description: The intervention consists of 7 sessions of CBT for the treatment of GAD. Each session contains a range of information and tasks/exercises to help the user understand the condition of GAD, the treatment approach, and how it will be applicable to them. The intervention is based on an evidence-based treatment protocol; hence the sessions will flow from one to the other and the user will complete the sessions in a progressive direction. However, they can repeat a session before going on to the next session. Once all sessions have been completed, the user can go back over any of the sessions. There are anxiety management exercises, which the user can go to whenever they wish. There are also a therapy reflection journal and self-care resources including further anxiety management techniques, resources, and podcasts that the user will have access to whenever they want.
Study NCT06146530 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Treatment
Description: The intervention consists of 7 sessions of CBT for the treatment of GAD. Each session contains a range of information and tasks/exercises to help the user understand the condition of GAD, the treatment approach, and how it will be applicable to them. The intervention is based on an evidence-based treatment protocol; hence the sessions will flow from one to the other and the user will complete the sessions in a progressive direction. However, they can repeat a session before going on to the next session. Once all sessions have been completed, the user can go back over any of the sessions. There are anxiety management exercises, which the user can go to whenever they wish. There are also a therapy reflection journal and self-care resources including further anxiety management techniques, resources, and podcasts that the user will have access to whenever they want.
Study NCT06484608 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Isotonic Saline with Dextrose
Description: This clinical trial involves two interventions for maintaining fluid therapy in neonates post-surgery. The first intervention, isotonic saline with dextrose, involves administering 0.9% saline solution combined with 5% dextrose. This isotonic solution aims to maintain serum sodium levels within the normal range and minimize the risk of hyponatremia and hypernatremia in postoperative neonates. The second intervention, hypotonic saline with dextrose, involves administering 0.45% saline solution combined with 5% dextrose. This hypotonic solution is being compared to the isotonic solution to evaluate its effectiveness in maintaining electrolyte balance.
Study NCT06726486 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Control (Standard treatment)
Description: A complete high-protein and high-calorie diet with mixed fibre was administered.
Study NCT06725394 — intervention group
Intervention type: OTHER
Intervention: Filling out the survey
Description: Data were collected using an information form, the Smartphone Addiction Scale-Short Version (SAS-SV), the Perceived Stress Scale (PSS-10), and the Neck Disability Index (NDI).
Study NCT06484608 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isotonic Saline with Dextrose
Description: This clinical trial involves two interventions for maintaining fluid therapy in neonates post-surgery. The first intervention, isotonic saline with dextrose, involves administering 0.9% saline solution combined with 5% dextrose. This isotonic solution aims to maintain serum sodium levels within the normal range and minimize the risk of hyponatremia and hypernatremia in postoperative neonates. The second intervention, hypotonic saline with dextrose, involves administering 0.45% saline solution combined with 5% dextrose. This hypotonic solution is being compared to the isotonic solution to evaluate its effectiveness in maintaining electrolyte balance.
Study NCT04925011 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Roxadustat
Description: Starting doses of 20, 50, 70 or 100 mg/30,70,90,or 120mg based on weight and dialysis or not.
Study NCT05248516 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Simplified dose of ready-to-use therapeutic food (RUTF)
Description: In the simplified arm all children receive the same dose: 1 sachet of RUTF/day. This until discharge from treatment.~Recovery from treatment will be defined as WAZ>= -3 on 2 consecutive visits. A maximum of 12 treatment weeks are allowed before declaring non-response. Defaulting will be declared after 2 consecutively missed visits.
Study NCT05248516 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Standard dose of ready-to-use therapeutic food (RUTF)
Description: In the standard arm, children will receive different doses of RUTF depending on their WHZ category and weight.~1. children with a WHZ\<-3 will receive the equivalent of 200kcal/kg/d of RUTF until discharge.~2. children with a WHZ between -3 and -2 will receive 1 sachet (500kcal) of RUTF per day until discharge.~3. children with a WHZ>=-2 will receive no nutritional treatment.~Recovery from treatment will be defined as WHZ>= -2 on 2 consecutive visits. A maximum of 12 treatment weeks are allowed before declaring non-response. Defaulting will be declared after 2 consecutively missed visits.
Study NCT05248516 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: No nutritional treatment
Description: no nutritional treatment will be provided to children in the control arm.
Study NCT05233566 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine
Description: NMDA antagonist
Study NCT05233566 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: IV fluid acting as a placebo
Study NCT06416865 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AJU-C52L, AJU-C52
Description: AJU-C52L+C52R1L placebo: Subjects take the investigational products once a day for 2 weeks.~AJU-C52+C52R1M placebo: Subjects take the investigational products once a day for 6 weeks.
Study NCT06416865 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C52R1L, C52R1M
Description: C52R1L+AJU-C52L placebo: Subjects take the investigational products once a day for 2 weeks.~C52R1M+AJU-C52 placebo: Subjects take the investigational products once a day for 6 weeks.
Study NCT05321394 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sotrovimab
Description: Single intravenous infusion of sotrovimab 500 mg (500 mg/8 mL), administered in 100 mL prefilled 0.9% sodium chloride injection infusion solution over 1/2 hour.
Study NCT05321394 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tixagevimab Cilgavimab
Description: 2 subsequent injections:~1. tixagevimab 300mg/3mL (100mg/mL)~2. cilgavimab 300mg/3mL (100mg/mL)
Study NCT05321394 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nirmatrelvir Ritonavir
Description: 300 mg nirmatrelvir (two 150 mg tablets) with 100 mg ritonavir (one 100 mg tablet) with all three tablets taken together twice daily for 5 days